QCBGX
Price
$22.54
Change
-$0.08 (-0.35%)
Updated
Aug 14 closing price
Net Assets
286.94M
RLBAX
Price
$37.14
Change
-$0.03 (-0.08%)
Updated
Aug 14 closing price
Net Assets
256.44B
Interact to see
Advertisement

QCBGX vs RLBAX

Header iconQCBGX vs RLBAX Comparison
Open Charts QCBGX vs RLBAXBanner chart's image
Federated Hermes MDT Balanced C
Price$22.54
Change-$0.08 (-0.35%)
VolumeN/A
Net Assets286.94M
American Funds American Balanced R1
Price$37.14
Change-$0.03 (-0.08%)
VolumeN/A
Net Assets256.44B
QCBGX vs RLBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
QCBGX vs. RLBAX commentary
Aug 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QCBGX is a Buy and RLBAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 256B vs. QCBGX (287M). RLBAX pays higher dividends than QCBGX: RLBAX (1.17) vs QCBGX (0.62). QCBGX was incepted earlier than RLBAX: QCBGX (20 years) vs RLBAX (23 years). QCBGX (2.12) is less costly to investors than RLBAX (1.31). QCBGX is a more actively managed with annual turnover of: 68.00 vs. RLBAX (44.00). RLBAX has a lower initial minimum investment than QCBGX: RLBAX (250) vs QCBGX (1500). RLBAX annual gain was more profitable for investors over the last year : 8.34 vs. QCBGX (4.45). RLBAX return over 5 years is better than : 34.06 vs. QCBGX (16.97).
QCBGXRLBAXQCBGX / RLBAX
Total Expense Ratio2.121.31162%
Annual Report Gross Expense Ratio2.121.31162%
Fund Existence20 years23 years-
Gain YTD9.2239.47997%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets287M256B0%
Annual Yield % from dividends0.621.1753%
Returns for 1 year4.458.3453%
Returns for 3 years16.8527.4261%
Returns for 5 years16.9734.0650%
Returns for 10 years41.6359.1470%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRZN10.850.79
+7.85%
Surrozen
APVO2.040.13
+6.81%
Aptevo Therapeutics Inc
KRT25.44-0.42
-1.62%
Karat Packaging
VCYT30.04-0.64
-2.09%
Veracyte
BALL53.64-1.25
-2.28%
Ball Corp